Wang Ronghua 4
4 · Biostar Pharmaceuticals, Inc. · Filed Jun 8, 2011
Insider Transaction Report
Form 4
Wang Ronghua
DirectorChairman, CEO10% Owner
Transactions
- Purchase
Common Stock
2011-06-06$1.24/sh+10,300$12,772→ 9,006,773 total - Purchase
Common Stock
2011-06-07$1.25/sh+8,600$10,750→ 9,015,373 total
Footnotes (1)
- [F1]Purchase made pursuant to the stock repurchase plan of the Reporting Person as previously approved by the Board of Directors.